The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.

Health care law monthly

Volumn , Issue , 2007, Pages 3-12

  Werling, Krist ^a   Abraham, Sarah ^a   Strelec, Jessica ^a  

^a Hardesty and Hanover LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; COMMERCIAL PHENOMENA; DRUG COST; DRUG INDUSTRY; ECONOMICS; GOVERNMENT; GOVERNMENT REGULATION; HEALTH CARE FACILITY; HUMAN; LEGAL ASPECT; MEDICAID; OUTPATIENT; PATIENT; SOCIAL WELFARE; UNITED STATES;

CHARITIES; COMMERCE; DRUG COSTS; DRUG INDUSTRY; GOVERNMENT REGULATION; HEALTH FACILITIES; HUMANS; MEDICAID; MEDICALLY UNINSURED; OUTPATIENTS; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION;

EID: 38449087953     PISSN: 15260704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)